Tolerance-inducing strategies in islet transplantation

International Journal of Endocrinology

Volumn 2012, Issue , 2012, Pages

  Bhatt, Sumantha ^a   Fung, John J ^b   Lu, Lina ^a,b   Qian, Shiguang ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Digestive Disease Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; B7 ANTIGEN; CD28 ANTIGEN; CD3 ANTIBODY; CD40 LIGAND MONOCLONAL ANTIBODY; DACLIZUMAB; INDUCIBLE NITRIC OXIDE SYNTHASE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

BONE MARROW CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLONAL ANERGY; DENDRITIC CELL; DIABETES MELLITUS; DONOR SPECIFIC TOLERANCE; GRAFT SURVIVAL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INTRACELLULAR SIGNALING; LOW DRUG DOSE; LYMPHOCYTOPENIA; MESENCHYMAL STROMA CELL; MICROCHIMERISM; MIXED CHIMERISM; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; RECEPTOR BLOCKING; REGULATORY T LYMPHOCYTE; REVIEW; SERTOLI CELL; STELLATE CELL; SUPPRESSOR CELL; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION; TRANSPLANTATION TOLERANCE; TREATMENT DURATION; WHOLE BODY RADIATION;

EID: 84862285965     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2012/396524     Document Type: Review

References (178)

1. Centers for Disease Control and Prevention, National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States 2011 Atlanta, Ga, USA U.S. Department of Health and Human Services, Centers for Disease Control and Prevention
2. Ricordi C., Strom T. B., Clinical islet transplantation: advances and immunological challenges Nature Reviews Immunology 2004 4 4 259 268 (Pubitemid 38478661)
3. Fiorina P., Shapiro A. M. J., Ricordi C., Secchi A., The clinical impact of islet transplantation American Journal of Transplantation 2008 8 10 1990 1997
4. Robertson R. P., Islet transplantation as a treatment for diabetesa work in progress The New England Journal of Medicine 2004 350 7 694 705 (Pubitemid 38364628)
5. Williams P. W., Notes on diabetes treated with extract andby grafts of sheeps pancreas BMJ 1894 2 1303 1304
6. Kemp C. B., Knight M. J., Scharp D. W., Effect of transplantation site on the results of pancreatic islet isografts in diabetic rats Diabetologia 1973 9 6 486 491
7. Kenyon N. S., Chatzipetrou M., Masetti M., Ranuncoli A., Oliveira M., Wagner J. L., Kirk A. D., Harlan D. M., Burkly L. C., Ricordi C., Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154 Proceedings of the National Academy of Sciences of the United States of America 1999 96 14 8132 8137 (Pubitemid 29328420)
8. Hermann M., Margreiter R., Hengster P., Islam M. S., Human islet autotransplantation: the trail thus far and the highway ahead The Islets of Langerhans 2010 654 Dordrecht, The Netherlands Springer 711 724
9. Ricordi C., Lacy P. E., Finke E. H., Olack B. J., Scharp D. W., Automated method for isolation of human pancreatic islets Diabetes 1988 37 4 413 420 (Pubitemid 18096377)
10. Lacy P. E., Kostianovsky M., Method for the isolation of intact islets of Langerhans from the rat pancreas Diabetes 1967 16 1 35 39
11. Scharp D. W., Lacy P. E., Santiago J. V., McCullough C. S., Weide L. G., Falqui L., Marchetti P., Gingerich R. L., Jaffe A. S., Cryer P. E., Anderson C. B., Flye M. W., Insulin independence after islet transplantation into type I diabetic patient Diabetes 1990 39 4 515 518 (Pubitemid 20111437)
12. Merani S., Shapiro A. M. J., Current status of pancreatic islet transplantation Clinical Science 2006 110 6 611 625 (Pubitemid 43844731)
13. Ingulli E., Mechanism of cellular rejection in transplantation Pediatric Nephrology 2010 25 1 61 74
14. Shapiro A. M. J., Hao E. G., Lakey J. R. T., Finegood D. T., Rajotte R. V., Kneteman N. M., Defining optimal immunosuppression for islet transplantation based on reduced diabetogenicity in canine islet autografts Transplantation 2002 74 11 1522 1528 (Pubitemid 36014224)
15. Shapiro A. M. J., Lakey J. R. T., Ryan E. A., Korbutt G. S., Toth E., Warnock G. L., Kneteman N. M., Rajotte R. V., Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen The New England Journal of Medicine 2000 343 4 230 238 (Pubitemid 30490390)
16. Ryan E. A., Lakey J. R. T., Rajotte R. V., Korbutt G. S., Kin T., Imes S., Rabinovitch A., Elliott J. F., Bigam D., Kneteman N. M., Warnock G. L., Larsen I., Shapiro A. M. J., Clinical outcomes and insulin secretion after islet transplantation with the edmonton protocol Diabetes 2001 50 4 710 719 (Pubitemid 32242625)
17. Monti P., Scirpoli M., Maffi P., Ghidoli N., De Taddeo F., Bertuzzi F., Piemonti L., Falcone M., Secchi A., Bonifacio E., Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells The Journal of Clinical Investigation 2008 118 5 1806 1814 (Pubitemid 351632383)
18. Shapiro A. M. J., Ricordi C., Hering B. J., Auchincloss H., Lindblad R., Robertson R. P., Secchi A., Brendel M. D., Berney T., Brennan D. C., Cagliero E., Alejandro R., Ryan E. A., DiMercurio B., Morel P., Polonsky K. S., Reems J. A., Bretzel R. G., Bertuzzi F., Froud T., Kandaswamy R., Sutherland D. E. R., Eisenbarth G., Segal M., Preiksaitis J., Korbutt G. S., Barton F. B., Viviano L., Seyfert-Margolis V., Bluestone J., Lakey J. R. T., International trial of the Edmonton protocol for islet transplantation The New England Journal of Medicine 2006 355 13 1318 1330 (Pubitemid 44465460)
19. Marcén R., Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection Drugs 2009 69 16 2227 2243
20. Sprent J., Kishimoto H., The thymus and central tolerance Philosophical Transactions of the Royal Society B 2001 356 1409 609 616 (Pubitemid 32575693)
21. Oluwole O. O., Depaz H. A., Gopinathan R., Ali A., Garrovillo M., Jin M. X., Hardy M. A., Oluwole S. F., Indirect allorecognition in acquired thymic tolerance Diabetes 2001 50 7 1546 1552
22. Oluwole S. F., Oluwole O. O., Adeyeri A. O., DePaz H. A., New strategies in immune tolerance induction Cell Biochemistry and Biophysics 2004 40 3 27 48
23. Britt L. D., Scharp D. W., Lacy P. E., Slavin S., Transplantation of islet cells across major histocompatibility barriers after total lymphoid irradiation and infusion of allogeneic bone marrow cells Diabetes 1982 31 supplement 4 63 68 (Pubitemid 12098715)
24. Li H., Kaufman C. L., Boggs S. S., Johnson P. C., Patrene K. D., Ildstad S. T., Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice The Journal of Immunology 1996 156 1 380 388
25. Horowitz M. M., Gale R. P., Sondel P. M., Goldman J. M., Kersey J., Kolb H. J., Rimm A. A., Ringden O., Rozman C., Speck B., Truitt R. L., Zwaan F. E., Bortin M. M., Graft-versus-leukemia reactions after bone marrow transplantation Blood 1990 75 3 555 562 (Pubitemid 20069191)
26. Mielcarek M., Martin P. J., Leisenring W., Flowers M. E. D., Maloney D. G., Sandmaier B. M., Maris M. B., Storb R., Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation Blood 2003 102 2 756 762 (Pubitemid 36842003)
27. Wekerle T., Kurtz J., Bigenzahn S., Takeuchi Y., Sykes M., Mechanisms of transplant tolerance induction using costimulatory blockade Current Opinion in Immunology 2002 14 5 592 600
28. Wekerle T., Sayegh M. H., Hill J., Zhao Y., Chandraker A., Swenson K. G., Zhao G., Sykes M., Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance Journal of Experimental Medicine 1998 187 12 2037 2044 (Pubitemid 28285573)
29. Wekerle T., Sykes M., Mixed chimerism and transplantation tolerance Annual Review of Medicine 2001 52 353 370 (Pubitemid 32195330)
30. Nikolic B., Takeuchi Y., Leykin I., Fudaba Y., Smith R. N., Sykes M., Mixed hematopoietic chimerism allows cure of autoimmune diabetes through allogeneic tolerance and reversal of autoimmunity Diabetes 2004 53 2 376 383 (Pubitemid 38174553)
31. Elkin G., Prighozina T. B., Gurevitch O., Slavin S., Nonmyeloablative bone marrow transplantation based on deletion of host-anti-donor alloreactive cells prevents autoimmune insulitis and diabetes in nonobese diabetic mice Transplantation Proceedings 2002 34 4 1303 1306 (Pubitemid 34665347)
32. Elkin G., Prigozhina T. B., Slavin S., Prevention of diabetes in nonobese diabetic mice by nonmyeloablative allogeneic bone marrow transplantation Experimental Hematology 2004 32 6 579 584 (Pubitemid 38739470)
33. Chatenoud L., Bluestone J. A., CD3-specific antibodies: a portal to the treatment of autoimmunity Nature Reviews Immunology 2007 7 8 622 632 (Pubitemid 47123550)
34. Chatenoud L., CD3-specific antibody-induced active tolerance: from bench to bedside Nature Reviews Immunology 2003 3 2 123 132 (Pubitemid 37328690)
35. Liang Y., Huang T., Zhang C., Todorov I., Atkinson M., Kandeel F., Forman S., Zeng D., Donor CD8 + T cells facilitate induction of chimerism and tolerance without GVHD in autoimmune NOD mice conditioned with anti-CD3 mAb Blood 2005 105 5 2180 2188 (Pubitemid 40731811)
36. Chatenoud L., Thervet E., Primo J., Bach J. F., Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice Proceedings of the National Academy of Sciences of the United States of America 1994 91 1 123 127 (Pubitemid 24018655)
37. Belghith M., Bluestone J. A., Barriot S., Mégret J., Bach J. F., Chatenoud L., TGF- -dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes Nature Medicine 2003 9 9 1202 1208 (Pubitemid 37173706)
38. Chen G., Han G., Wang J., Wang R., Xu R., Shen B., Qian J., Li Y., Essential roles of TGF- in anti-CD3 antibody therapy: reversal of diabetes in nonobese diabetic mice independent of FoxP3 + CD4 + regulatory T cells Journal of Leukocyte Biology 2008 83 2 280 287 (Pubitemid 351225608)
39. Thomas J. M., Contreras J. L., Smyth C. A., Lobashevsky A., Jenkins S., Hubbard W. J., Eckhoff D. E., Stavrou S., Neville D. M., Thomas F. T., Successful reversal of streptozotocin-induced diabetes with stable allogeneic islet function in a preclinical model of type 1 diabetes Diabetes 2001 50 6 1227 1236 (Pubitemid 32500153)
40. Hering B. J., Kandaswamy R., Ansite J. D., Eckman P. M., Nakano M., Sawada T., Matsumoto I., Ihm S. H., Zhang H. J., Parkey J., Hunter D. W., Sutherland D. E. R., Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes JAMA 2005 293 7 830 835 (Pubitemid 40250366)
41. Hirshberg B., Rother K. I., Digon B. J., Lee J., Gaglia J. L., Hines K., Read E. J., Chang R., Wood B. J., Harlan D. M., Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience Diabetes Care 2003 26 12 3288 3295 (Pubitemid 37466889)
42. Préville X., Flacher M., LeMauff B., Beauchard S., Davelu P., Tiollier J., Revillard J. P., Mechanisms involved in antithymocyte globulin immunosuppressive activity in a nonhuman primate model Transplantation 2001 71 3 460 468 (Pubitemid 32175986)
43. Friedman E. A., Beyer M. M., Effect of antithymocyte globulin on islet of Langerhans transplantation Nephron 1978 22 13 212 216
44. Liu C., Noorchashm H., Sutter J. A., Naji M., Prak E. L., Boyer J., Green T., Rickels M. R., Tomaszewski J. E., Koeberlein B., Wang Z., Paessler M. E., Velidedeoglu E., Rostami S. Y., Yu M., Barker C. F., Naji A., B lymphocyte-directed immunotherapy promotes long-term islet allograft survival in nonhuman primates Nature Medicine 2007 13 11 1295 1298 (Pubitemid 350073600)
45. Guinan E. C., Gribben J. G., Boussiotis V. A., Freeman G. J., Nadler L. M., Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity Blood 1994 84 10 3261 3282 (Pubitemid 24352887)
46. Pearson T. C., Alexander D. Z., Winn K. J., Linsley P. S., Lowry R. P., Larsen C. P., Transplantation tolerance induced by CTLA4-Ig Transplantation 1994 57 12 1701 1706 (Pubitemid 24206406)
47. Lenschow D. J., Zeng Y., Thistlethwaite J. R., Montag A., Brady W., Gibson M. G., Linsley P. S., Bluestone J. A., Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig Science 1992 257 5071 789 792
48. Turka L. A., Linsley P. S., Lin H., Brady W., Leiden J. M., Wei R. Q., Gibson M. L., Zheng X. G., Myrdal S., Gordon D., Bailey T., Bolling S. F., Thompson C. B., T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo Proceedings of the National Academy of Sciences of the United States of America 1992 89 22 11102 11105
49. Levisetti M. G., Padrid P. A., Szot G. L., Mittal N., Meehan S. M., Wardrip C. L., Gray G. S., Bruce D. S., Thistlethwaite J. R., Bluestone J. A., Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation The Journal of Immunology 1997 159 11 5187 5191 (Pubitemid 127470041)
50. Foy T. M., Aruffo A., Bajorath J., Buhlmann J. E., Noelle R. J., Immune regulation by CD40 and its ligand GP39 Annual Review of Immunology 1996 14 591 617 (Pubitemid 26130658)
51. Van Kooten G., Banchereau J., CD40-CD40 ligand Journal of Leukocyte Biology 2000 67 1 2 17 (Pubitemid 30046812)
52. Parker D. C., Greiner D. L., Phillips N. E., Appel M. C., Steele A. W., Durie F. H., Noelle R. J., Mordes J. P., Rossini A. A., Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand Proceedings of the National Academy of Sciences of the United States of America 1995 92 21 9560 9564
53. Kenyon N. S., Fernandez L. A., Lehmann R., Masetti M., Ranuncoli A., Chatzipetrou M., Iaria G., Han D., Wagner J. L., Ruiz P., Berho M., Inverardi L., Alejandro R., Mintz D. H., Kirk A. D., Harlan D. M., Burkly L. C., Ricordi C., Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154 Diabetes 1999 48 7 1473 1481 (Pubitemid 29297314)
54. Shimizu K., Schonbeck U., Mach F., Libby P., Mitchell R. N., Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis The Journal of Immunology 2000 165 6 3506 3518
55. Koulmanda M., Smith R. N., Qipo A., Weir G., Auchincloss H., Strom T. B., Prolonged survival of allogeneic islets in cynomolgus monkeys after short-term anti-CD154-based therapy: nonimmunologic graft failure? American Journal of Transplantation 2006 6 4 687 696 (Pubitemid 43345006)
56. Iwakoshi N. N., Mordes J. P., Markees T. G., Phillips N. E., Rossini A. A., Greiner D. L., Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8 + T cells and prolonged graft survival in a CTLA4-dependent manner The Journal of Immunology 2000 164 1 512 521 (Pubitemid 30013028)
57. Durham M. M., Bingaman A. W., Adams A. B., Ha J., Waitze S. Y., Pearson T. C., Larsen C. P., Cutting edge: administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning The Journal of Immunology 2000 165 1 1 4 (Pubitemid 30429481)
58. Kirk A. D., Harlan D. M., Armstrong N. N., Davis T. A., Dong Y., Gray G. S., Hong X., Thomas D., Fechner J. H., Knechtle S. J., CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates Proceedings of the National Academy of Sciences of the United States of America 1997 94 16 8789 8794 (Pubitemid 27335118)
59. Azimzadeh A. M., Pfeiffer S., Wu G., Schrder C., Zorn G. L., Kelishadi S. S., Ozkaynak E., Kehry M., Atkinson J. B., Miller G. G., Pierson R. N., Alloimmunity in primate heart recipients with CD154 blockade: evidence for alternative costimulation mechanisms Transplantation 2006 81 2 255 264
60. Koyama I., Kawai T., Andrews D., Boskovic S., Nadazdin O., Wee S. L., Sogawa H., Wu D. L., Smith R. N., Colvin R. B., Sachs D. H., Cosimi A. B., Thrombophilia associated with anti-CD154 monoclonal antibody treatment and its prophylaxis in nonhuman primates Transplantation 2004 77 3 460 462 (Pubitemid 38209752)
61. Van Kooten C., Lombardi G., Gelderman K. A., Sagoo P., Buckland M., Lechler R., Cuturi M. C., Dendritic cells as a tool to induce transplantation tolerance: obstacles and opportunities Transplantation 2011 91 1 2 7
62. Lu L., Thomson A. W., Genetic engineering of dendritic cells to enhance their tolerogenic potential Graft 2002 5 5 308 314
63. Shortman K., Liu Y. J., Mouse and human dendritic cell subtypes Nature Reviews Immunology 2002 2 3 151 161 (Pubitemid 37336516)
64. Youn J. I., Nagaraj S., Collazo M., Gabrilovich D. I., Subsets of myeloid-derived suppressor cells in tumor-bearing mice The Journal of Immunology 2008 181 8 5791 5802
65. Thomson A. W., Lu L., Murase N., Demetris A. J., Rao A. S., Starzl T. E., Microchimerism, dendritic cell progenitors and transplantation tolerance Stem Cells 1995 13 6 622 639
66. Christensen H. R., Frkir H., Pestka J. J., Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells The Journal of Immunology 2002 168 1 171 178 (Pubitemid 34014116)
67. Li M., Zhang X., Zheng X., Lian D., Zhang Z. X., Sun H., Suzuki M., Vladau C., Huang X., Xia X., Zhong R., Garcia B., Min W. P., Tolerogenic dendritic cells transferring hyporesponsiveness and synergizing T regulatory cells in transplant tolerance International Immunology 2008 20 2 285 293 (Pubitemid 351234396)
68. Tiao M. M., Lu L., Tao R., Wang L., Fung J. J., Qian S., Prolongation of cardiac allograft survival by systemic administration of immature recipient dendritic cells deficient in NF- B activity Annals of Surgery 2005 241 3 497 505 (Pubitemid 40299728)
69. Luo X., Tarbell K. V., Yang H., Pothoven K., Bailey S. L., Ding R., Steinman R. M., Suthanthiran M., Dendritic cells with TGF- 1 differentiate nave CD4 + CD25- T cells into islet-protective Foxp3 + regulatory T cells Proceedings of the National Academy of Sciences of the United States of America 2007 104 8 2821 2826 (Pubitemid 46327963)
70. Munn D. H., Sharma M. D., Baban B., Harding H. P., Zhang Y., Ron D., Mellor A. L., GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase Immunity 2005 22 5 633 642 (Pubitemid 40719198)
71. Sonenberg N., Hershey J. W. B., Mathews M. B., Translational Control of Gene Expression 2001 CSHL Press
72. Ochando J. C., Homma C., Yang Y., Hidalgo A., Garin A., Tacke F., Angeli V., Li Y., Boros P., Ding Y., Jessberger R., Trinchieri G., Lira S. A., Randolph G. J., Bromberg J. S., Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts Nature Immunology 2006 7 6 652 662 (Pubitemid 43797347)
73. Mackey M. F., Gunn J. R., Maliszewski C., Kikutani H., Noelle R. J., Barth R. J., Cutting edge: dendritic cells require maturation via CD40 to generate protective antitumor immunity The Journal of Immunology 1998 161 5 2094 2098 (Pubitemid 28397017)
74. De Smedt T., Van Mechelen M., De Becker G., Urbain J., Leo O., Moser M., Effect of interleukin-10 on dendritic cell maturation and function European Journal of Immunology 1997 27 5 1229 1235 (Pubitemid 27197228)
75. Lutz M. B., Suri R. M., Niimi M., Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo European Journal of Immunology 2000 30 7 1813 1822 (Pubitemid 30456177)
76. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., Muramatsu S., Steinman R. M., Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor Journal of Experimental Medicine 1992 176 6 1693 1702
77. Garrigan K., Moroni-Rawson P., McMurray C., Hermans I., Abernethy N., Watson J., Ronchese F., Functional comparison of spleen dendritic cells and dendritic cells cultured in vitro from bone marrow precursors Blood 1996 88 9 3508 3512 (Pubitemid 26365586)
78. Turnquist H. R., Raimondi G., Zahorchak A. F., Fischer R. T., Wang Z., Thomson A. W., Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4 + T cells, but enrich for antigen-specific Foxp3 + T regulatory cells and promote organ transplant tolerance The Journal of Immunology 2007 178 11 7018 7031 (Pubitemid 46847428)
79. Ma L., Qian S., Liang X., Wang L., Woodward J. E., Giannoukakis N., Robbins P. D., Bertera S., Trucco M., Fung J. J., Lu L., Prevention of diabetes in NOD mice by administration of dendritic cells deficient in nuclear transcription factor- B activity Diabetes 2003 52 8 1976 1985 (Pubitemid 36919789)
80. Bonham C. A., Peng L., Liang X., Chen Z., Wang L., Ma L., Hackstein H., Robbins P. D., Thomson A. W., Fung J. J., Qian S., Lu L., Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF- B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig The Journal of Immunology 2002 169 6 3382 3391 (Pubitemid 35013188)
81. Min W. P., Gorczynski R., Huang X. Y., Kushida M., Kim P., Obataki M., Lei L., Suri R. M., Cattral M. S., Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival The Journal of Immunology 2000 164 1 161 167 (Pubitemid 30012986)
82. Lu L., Lee W. C., Takayama T., Qian S., Gambotto A., Robbins P. D., Thomson A. W., Genetic engineering of dendritic cells to express immunosuppressive molecules (viral IL-10, TGF-, and CTLA4Ig) Journal of Leukocyte Biology 1999 66 2 293 296 (Pubitemid 29379171)
83. Lu L., Gambotto A., Lee W. C., Qian S., Bonham C. A., Robbins P. D., Thomson A. W., Adenoviral delivery of CTLA4lg into myeloid dendritic cells promotes their in vitro tolerogenicity and survival in allogeneic recipients Gene Therapy 1999 6 4 554 563 (Pubitemid 29192664)
84. Almand B., Clark J. I., Nikitina E., Van Beynen J., English N. R., Knight S. C., Carbone D. P., Gabrilovich D. I., Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer The Journal of Immunology 2001 166 1 678 689 (Pubitemid 32038493)
85. Diaz-Montero C. M., Salem M. L., Nishimura M. I., Garrett-Mayer E., Cole D. J., Montero A. J., Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy Cancer Immunology, Immunotherapy 2009 58 1 49 59
86. Peranzoni E., Zilio S., Marigo I., Dolcetti L., Zanovello P., Mandruzzato S., Bronte V., Myeloid-derived suppressor cell heterogeneity and subset definition Current Opinion in Immunology 2010 22 2 238 244
87. Gabrilovich D. I., Nagaraj S., Myeloid-derived suppressor cells as regulators of the immune system Nature Reviews Immunology 2009 9 3 162 174
88. Kusmartsev S., Nefedova Y., Yoder D., Gabrilovich D. I., Antigen-Specific Inhibition of CD8 + T Cell Response by Immature Myeloid Cells in Cancer Is Mediated by Reactive Oxygen Species The Journal of Immunology 2004 172 2 989 999 (Pubitemid 38113758)
89. Bronte V., Zanovello P., Regulation of immune responses by L-arginine metabolism Nature Reviews Immunology 2005 5 8 641 654 (Pubitemid 41113195)
90. Zhu B., Bando Y., Xiao S., Yang K., Anderson A. C., Kuchroo V. K., Khoury S. J., CD11b + Ly-6 Chi suppressive monocytes in experimental autoimmune encephalomyelitis The Journal of Immunology 2007 179 8 5228 5237
91. Ilkovitch D., Lopez D. M., Immune modulation by melanoma-derived factors Experimental Dermatology 2008 17 12 977 985
92. Greifenberg V., Ribechini E., Rner S., Lutz M. B., Myeloid-derived suppressor cell activation by combined LPS and IFN- treatment impairs DC development European Journal of Immunology 2009 39 10 2865 2876
93. Bronte V., Myeloid-derived suppressor cells in inflammation: uncovering cell subsets with enhanced immunosuppressive functions European Journal of Immunology 2009 39 10 2670 2672
94. Serafini P., Carbley R., Noonan K. A., Tan G., Bronte V., Borrello I., High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells Cancer Research 2004 64 17 6337 6343 (Pubitemid 39129439)
95. Gabrilovich D., Ishida T., Oyama T., Ran S., Kravtsov V., Nadaf S., Carbone D. P., Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo Blood 1998 92 11 4150 4166 (Pubitemid 28544331)
96. Bunt S. K., Sinha P., Clements V. K., Leips J., Ostrand-Rosenberg S., Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression The Journal of Immunology 2006 176 1 284 290 (Pubitemid 43023273)
97. Bunt S. K., Yang L., Sinha P., Clements V. K., Leips J., Ostrand-Rosenberg S., Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression Cancer Research 2007 67 20 10019 10026 (Pubitemid 47621253)
98. Song X., Krelin Y., Dvorkin T., Bjorkdahl O., Segal S., Dinarello C. A., Voronov E., Apte R. N., CD11b+/Gr-1+ immature myeloid cells mediate suppression of T cells in mice bearing tumors of IL-1 -secreting cells The Journal of Immunology 2005 175 12 8200 8208 (Pubitemid 41798384)
99. Nagaraj S., Gabrilovich D. I., Tumor escape mechanism governed by myeloid-derived suppressor cells Cancer Research 2008 68 8 2561 2563 (Pubitemid 351556251)
100. Cripps J. G., Gorham J. D., MDSC in autoimmunity International Immunopharmacology 2011 11 7 789 793
101. Van Ginderachter J. A., Beschin A., De Baetselier P., Raes G., Myeloid-derived suppressor cells in parasitic infections European Journal of Immunology 2010 40 11 2976 2985
102. Rodriguez P. C., Zea A. H., Culotta K. S., Zabaleta J., Ochoa Augusto C Ochoa J. B., Regulation of T cell receptor CD3 chain expression by L-arginine The Journal of Biological Chemistry 2002 277 24 21123 21129 (Pubitemid 34952247)
103. Peyton K. J., Ensenat D., Azam M. A., Arginase promotes neointima formation in rat injured carotid arteries Arteriosclerosis, Thrombosis, and Vascular Biology 2009 29 4 488 494
104. Bingisser R. M., Tilbrook P. A., Holt P. G., Kees U. R., Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway The Journal of Immunology 1998 160 12 5729 5734 (Pubitemid 28298028)
105. Harari O., Liao J. K., Inhibition of MHC II gene transcription by nitric oxide and antioxidants Current Pharmaceutical Design 2004 10 8 893 898 (Pubitemid 38380067)
106. Chung H. T., Pae H. O., Choi B. M., Billiar T. R., Kim Y. M., Breakthroughs and views: nitric oxide as a bioregulator of apoptosis Biochemical and Biophysical Research Communications 2001 282 5 1075 1079 (Pubitemid 32912833)
107. Nagaraj S., Gupta K., Pisarev V., Kinarsky L., Sherman S., Kang L., Herber D. L., Schneck J., Gabrilovich D. I., Altered recognition of antigen is a mechanism of CD8 + T cell tolerance in cancer Nature Medicine 2007 13 7 828 835 (Pubitemid 47038194)
108. Ostrand-Rosenberg S., Sinha P., Myeloid-derived suppressor cells: linking inflammation and cancer The Journal of Immunology 2009 182 8 4499 4506
109. Dugast A. S., Haudebourg T., Coulon F., Heslan M., Haspot F., Poirier N., De Silly R. V., Usal C., Smit H., Martinet B., Thebault P., Renaudin K., Vanhove B., Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector t cell expansion The Journal of Immunology 2008 180 12 7898 7906
110. De Wilde V., Van Rompaey N., Hill M., Lebrun J. F., Lematre P., Lhommé F., Kubjak C., Vokaer B., Oldenhove G., Charbonnier L. M., Cuturi M. C., Goldman M., Le Moine A., Endotoxin-induced myeloid-derived suppressor cells inhibit alloimmune responses via heme oxygenase-1 American Journal of Transplantation 2009 9 9 2034 2047
111. Chou H.-S., Hsieh C.-C., Charles R., Myeloid-derived suppressor cells protect islet transplants by b7-h1 mediated enhancement of T regulatory cells Transplantation 2012 93 3 272 282
112. Chou H. S., Hsieh C. C., Yang H. R., Wang L., Arakawa Y., Brown K., Wu Q., Lin F., Peters M., Fung J. J., Lu L., Qian S., Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice Hepatology 2011 53 3 1007 1019
113. Golshayan D., Wyss J. C., Abulker C. W., Schaefer S. C., Lechler R. I., Lehr H. A., Pascual M., Transplantation tolerance induced by regulatory T cells: in vivo mechanisms and sites of action International Immunopharmacology 2009 9 6 683 688
114. Golshayan D., Jiang S., Tsang J., Garin M. I., Mottet C., Lechler R. I., In vitro-expanded donor alloantigen-specific CD4 + CD25 + regulatory T cells promote experimental transplantation tolerance Blood 2007 109 2 827 835 (Pubitemid 46105988)
115. Graca L., Cobbold S. P., Waldmann H., Identification of regulatory T cells in tolerated allografts Journal of Experimental Medicine 2002 195 12 1641 1646 (Pubitemid 34666077)
116. Jiang S., Regulatory T Cells and Clinical Application 2009 New York, NY, USA Springer
117. Josefowicz S. Z., Rudensky A., Control of regulatory T cell lineage commitment and maintenance Immunity 2009 30 5 616 625
118. Piccirillo C. A., d'Hennezel E., Sgouroudis E., Yurchenko E., CD4 + Foxp3 + regulatory T cells in the control of autoimmunity: in vivo veritas Current Opinion in Immunology 2008 20 6 655 662
119. Carreras J., Lopez-Guillermo A., Fox B. C., Colomo L., Martinez A., Roncador G., Montserrat E., Campo E., Banham A. H., High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma Blood 2006 108 9 2957 2964
120. Li Y., Zhao X., Cheng D., Haga H., Tsuruyama T., Wood K., Sakaguchi S., Tanaka K., Uemoto S., Koshiba T., The presence of Foxp3 expressing T cells within grafts of tolerant human liver transplant recipients Transplantation 2008 86 12 1837 1843
121. Spoerl S., Li X. C., Regulatory T cells and the quest for transplant tolerance Discovery Medicine 2011 11 56 25 34
122. Noris M., Casiraghi F., Todeschini M., Cravedi P., Cugini D., Monteferrante G., Aiello S., Cassis L., Gotti E., Gaspari F., Cattaneo D., Perico N., Remuzzi G., Regulatory T cells and T cell depletion: role of immunosuppressive drugs Journal of the American Society of Nephrology 2007 18 3 1007 1018 (Pubitemid 46434518)
123. Maeda A., Schwarz A., Kernebeck K., Gross N., Aragane Y., Peritt D., Schwarz T., Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells The Journal of Immunology 2005 174 10 5968 5976 (Pubitemid 40663783)
124. Wang Z., Larregina A. T., Shufesky W. J., Perone M. J., Montecalvo A., Zahorchak A. F., Thomson A. W., Morelli A. E., Use of the inhibitory effect of apoptotic cells on dendritic cells for graft survival via T-cell deletion and regulatory T cells American Journal of Transplantation 2006 6 6 1297 1311 (Pubitemid 44030313)
125. Sakaguchi S., Yamaguchi T., Nomura T., Ono M., Regulatory T cells and immune tolerance Cell 2008 133 5 775 787 (Pubitemid 351707693)
126. Walsh P. T., Taylor D. K., Turka L. A., Tregs and transplantation tolerance The Journal of Clinical Investigation 2004 114 10 1398 1403 (Pubitemid 40385567)
127. Zhang N., Schrppel B., Lal G., Jakubzick C., Mao X., Chen D., Yin N., Jessberger R., Ochando J. C., Ding Y., Bromberg J. S., Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response Immunity 2009 30 3 458 469
128. Giraud S., Barrou B., Sebillaud S., Debré P., Klatzmann D., Thomas-Vaslin V., Transient depletion of dividing T lymphocytes in mice induces the emergence of regulatory T cells and dominant tolerance to islet allografts American Journal of Transplantation 2008 8 5 942 953 (Pubitemid 351537769)
129. Li W., Carper K., Liang Y., Zheng X. X., Kuhr C. S., Reyes J. D., Perkins D. L., Thomson A. W., Perkins J. D., Anti-CD25 mAb administration prevents spontaneous liver transplant tolerance Transplantation Proceedings 2006 38 10 3207 3208 (Pubitemid 44908478)
130. Zheng X. X., Snchez-Fueyo A., Sho M., Domenig C., Sayegh M. H., Strom T. B., Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance Immunity 2003 19 4 503 514 (Pubitemid 37311432)
131. Segundo D. S., Ruiz J. C., Izquierdo M., Fernndez-Fresnedo G., Gmez-Alamillo C., Merino R., Benito M. J., Cacho E., Rodrigo E., Palomar R., Lpez-Hoyos M., Arias M., Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4 + CD25 + Foxp3 + regulatory T cells in renal transplant recipients Transplantation 2006 82 4 550 557 (Pubitemid 44290262)
132. Coenen J. J. A., Koenen H. J. P. M., van Rijssen E., Kasran A., Boon L., Hilbrands L. B., Joosten I., Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4 + CD25 + FoxP3 + T cells Bone Marrow Transplantation 2007 39 9 537 545 (Pubitemid 46629589)
133. Riley J. L., June C. H., Blazar B. R., Human T regulatory cell therapy: take a billion or so and call me in the morning Immunity 2009 30 5 656 665
134. Dresske B., Lin X., Huang D. S., Zhou X., Fndrich F., Spontaneous tolerance: experience with the rat liver transplant model Human Immunology 2002 63 10 853 861 (Pubitemid 35246765)
135. Crispe I. N., Giannandrea M., Klein I., John B., Sampson B., Wuensch S., Cellular and molecular mechanisms of liver tolerance Immunological Reviews 2006 213 1 101 118 (Pubitemid 44401496)
136. Tiegs G., Lohse A. W., Immune tolerance: what is unique about the liver Journal of Autoimmunity 2010 34 1 1 6
137. Yu M. C., Chen C. H., Liang X., Wang L., Gandhi C. R., Fung J. J., Lu L., Qian S., Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice Hepatology 2004 40 6 1312 1321 (Pubitemid 39657005)
138. You Q., Cheng L., Kedl R. M., Ju C., Mechanism of T cell tolerance induction by murine hepatic Kupffer cells Hepatology 2008 48 3 978 990
139. Morita M., Fujino M., Jiang G., Kitazawa Y., Xie L., Azuma M., Yagita H., Nagao S., Sugioka A., Kurosawa Y., Takahara S., Fung J., Qian S., Lu L., Li X. K., PD-1/B7-H1 interaction contribute to the spontaneous acceptance of mouse liver allograft American Journal of Transplantation 2010 10 1 40 46
140. Bumgardner G. L., Gao D., Li J., Baskin J. H., Heininger M., Orosz C. G., Rejection responses to allogeneic hepatocytes by reconstituted SCID mice, CD4 KO, and CD8 KO mice1,2 Transplantation 2000 70 12 1771 1780 (Pubitemid 32064833)
141. Bumgardner G. L., Orosz C. G., Unusual patterns of alloimmunity evoked by allogeneic liver parenchymal cells Immunological Reviews 2000 174 260 279 (Pubitemid 30201394)
142. Geerts A., History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells Seminars in Liver Disease 2001 21 3 311 335 (Pubitemid 32923763)
143. Senoo H., Structure and function of hepatic stellate cells Medical Electron Microscopy 2004 37 1 3 15 (Pubitemid 38514675)
144. Sato M., Suzuki S., Senoo H., Hepatic stellate cells: unique characteristics in cell biology and phenotype Cell Structure and Function 2003 28 2 105 112 (Pubitemid 36790453)
145. Jiang G., Yang H. R., Wang L., Wildey G. M., Fung J., Qian S., Lu L., Hepatic stellate cells preferentially expand allogeneic CD4 + CD25 + FoxP3 + regulatory T cells in an IL-2-dependent manner Transplantation 2008 86 11 1492 1502
146. Yang H. R., Chou H. S., Gu X., Wang L., Brown K. E., Fung J. J., Lu L., Qian S., Mechanistic insights into immunomodulation by hepatic stellate cells in mice: a critical role of interferon- signaling Hepatology 2009 50 6 1981 1991
147. Chen C. H., Kuo L. M., Chang Y., Wu W., Goldbach C., Ross M. A., Stolz D. B., Chen L., Fung J. J., Lu L., Qian S., In vivo immune modulatory activity of hepatic stellate cells in mice Hepatology 2006 44 5 1171 1181 (Pubitemid 44748368)
148. Huang B., Pan P. Y., Li Q., Sato A. I., Levy D. E., Bromberg J., Divino C. M., Chen S. H., Gr-1 + CD115 + immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host Cancer Research 2006 66 2 1123 1131 (Pubitemid 43165981)
149. Benten D., Kumaran V., Joseph B., Schattenberg J., Popov Y., Schuppan D., Gupta S., Hepatocyte transplantation activates hepatic stellate cells with beneficial modulation of cell engraftment in the rat Hepatology 2005 42 5 1072 1081 (Pubitemid 43112674)
150. Suarez-Pinzon W., Korbutt G. S., Power R., Hooton J., Rajotte R. V., Rabinovitch A., Testicular Sertoli cells protect islet -cells from autoimmune destruction in NOD mice by a transforming growth factor- 1-dependent mechanism Diabetes 2000 49 11 1810 1818
151. Yang H., Wright J. R., Co-encapsulation of sertoli enriched testicular cell fractions further prolongs fish-to-mouse islet xenograft survival Transplantation 1999 67 6 815 820 (Pubitemid 29169125)
152. Emerich D. F., Hemendinger R., Halberstadt C. R., The testicular-derived sertoli cell: cellular immunoscience to enable transplantation Cell Transplantation 2003 12 4 335 349 (Pubitemid 36919034)
153. Halberstadt C., Emerich D. F., Gores P., Use of Sertoli cell transplants to provide local immunoprotection for tissue grafts Expert Opinion on Biological Therapy 2004 4 6 813 825 (Pubitemid 38843219)
154. Korbutt G. S., Elliott J. F., Rajotte R. V., Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression Diabetes 1997 46 2 317 322 (Pubitemid 27272268)
155. Mital P., Kaur G., Dufour J. M., Immunoprotective Sertoli cells: making allogeneic and xenogeneic transplantation feasible Reproduction 2010 139 3 495 504
156. Ramji Q. A., Bayrack K., Arefanian H., Protection of porcine islet xenografts in mice using sertoli cells and monoclonal antibodies Transplantation 2011 92 12 1309 1315
157. Fallarino F., Luca G., Calvitti M., Mancuso F., Nastruzzi C., Fioretti M. C., Grohmann U., Becchetti E., Burgevin A., Kratzer R., Van Endert P., Boon L., Puccetti P., Calafiore R., Therapy of experimental type 1 diabetes by isolated Sertoli cell xenografts alone Journal of Experimental Medicine 2009 206 11 2511 2526
158. Selawry H. P., Cameron D. F., Sertoli cell-enriched fractions in successful islet cell transplantation Cell Transplantation 1993 2 2 123 129 (Pubitemid 23134489)
159. De Cesaris P., Filippini A., Cervelli C., Riccioli A., Muci S., Starace G., Stefanini M., Ziparo E., Immunosuppressive molecules produced by Sertoli cells cultured in vitro: biological effects on lymphocytes Biochemical and Biophysical Research Communications 1992 186 3 1639 1646 (Pubitemid 23189514)
160. Lee H. M., Byoung C. O., Lim D. P., Lee D. S., Lim H. G., Chun S. P., Jeong R. L., Mechanism of humoral and cellular immune modulation provided by porcine Sertoli cells Journal of Korean Medical Science 2008 23 3 514 520
161. Selawry H. P., Whittington K., Extended allograft survival of islets grafted into intra-abdominally placed testis Diabetes 1984 33 4 405 406 (Pubitemid 14169544)
162. Selawry H. P., Whittington K. B., Prolonged intratesticular islet allograft survival in not dependent on local steroidogenesis Hormone and Metabolic Research 1988 20 9 562 565
163. Yin Z., Chen D., Hu F., Ruan Y., Li J., Wang L., Xiang Y., Xie L., Wang X., Ichim T. E., Chen S., Chen G., Cotransplantation with xenogenetic neonatal porcine Sertoli cells significantly prolongs islet allograft survival in nonimmunosuppressive rats Transplantation 2009 88 3 339 345
164. Valdés-Gonzlez R. A., Dorantes L. M., Garibay G. N., Bracho-Blanchet E., Mendez A. J., Dvila-Pérez R., Elliott R. B., Tern L., White D. J. G., Xenotransplantation of porcine neonatal islets of Langerhans and Sertoli cells: a 4-year study European Journal of Endocrinology 2005 153 3 419 427 (Pubitemid 41410499)
165. Pittenger M. F., Mackay A. M., Beck S. C., Jaiswal R. K., Douglas R., Mosca J. D., Moorman M. A., Simonetti D. W., Craig S., Marshak D. R., Multilineage potential of adult human mesenchymal stem cells Science 1999 284 5411 143 147 (Pubitemid 29282067)
166. Aggarwal S., Pittenger M. F., Human mesenchymal stem cells modulate allogeneic immune cell responses Blood 2005 105 4 1815 1822 (Pubitemid 40223708)
167. Ding Y., Xu D., Feng G., Bushell A., Muschel R. J., Wood K. J., Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9 Diabetes 2009 58 8 1797 1806
168. Ryan J. M., Barry F. P., Murphy J. M., Mahon B. P., Mesenchymal stem cells avoid allogeneic rejection Journal of Inflammation 2005 2 1, article 8
169. Fiorina P., Jurewicz M., Augello A., Vergani A., Dada S., La Rosa S., Selig M., Godwin J., Law K., Placidi C., Smith R. N., Capella C., Rodig S., Adra C. N., Atkinson M., Sayegh M. H., Abdi R., Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes The Journal of Immunology 2009 183 2 993 1004
170. Casiraghi F., Azzollini N., Cassis P., Imberti B., Morigi M., Cugini D., Cavinato R. A., Todeschini M., Solini S., Sonzogni A., Perico N., Remuzzi G., Noris M., Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells The Journal of Immunology 2008 181 6 3933 3946
171. Berman D. M., Willman M. A., Han D., Kleiner G., Kenyon N. M., Cabrera O., Karl J. A., Wiseman R. W., O'Connor D. H., Bartholomew A. M., Kenyon N. S., Mesenchymal stem cells enhance allogeneic islet engraftment in nonhuman primates Diabetes 2010 59 10 2558 2568
172. Baksh D., Song L., Tuan R. S., Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy Journal of Cellular and Molecular Medicine 2004 8 3 301 316 (Pubitemid 44145494)
173. Bartholomew A., Sturgeon C., Siatskas M., Ferrer K., McIntosh K., Patil S., Hardy W., Devine S., Ucker D., Deans R., Moseley A., Hoffman R., Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo Experimental Hematology 2002 30 1 42 48 (Pubitemid 34059216)
174. Inoue S., Popp F. C., Koehl G. E., Piso P., Schlitt H. J., Geissler E. K., Dahlke M. H., Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model Transplantation 2006 81 11 1589 1595 (Pubitemid 43890897)
175. Ezquer F. E., Ezquer M. E., Parrau D. B., Carpio D., Yaez A. J., Conget P. A., Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice Biology of Blood and Marrow Transplantation 2008 14 6 631 640
176. Sordi V., Malosio M. L., Marchesi F., Mercalli A., Melzi R., Giordano T., Belmonte N., Ferrari G., Leone B. E., Bertuzzi F., Zerbini G., Allavena P., Bonifacio E., Piemonti L., Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets Blood 2005 106 2 419 427 (Pubitemid 40981232)
177. Sordi V., Melzi R., Mercalli A., Formicola R., Doglioni C., Tiboni F., Ferrari G., Nano R., Chwalek K., Lammert E., Bonifacio E., Piemonti L., Mesenchymal cells appearing in pancreatic tissue culture are bone marrow-derived stem cells with the capacity to improve transplanted islet function Stem Cells 2010 28 1 140 151
178. Rackham C. L., Chagastelles P. C., Nardi N. B., Hauge-Evans A. C., Jones P. M., King A. J. F., Co-transplantation of mesenchymal stem cells maintains islet organisation and morphology in mice Diabetologia 2011 54 5 1127 1135